Showing results (61-70 of 92) with videos related to

Sort By:
Pageof 10
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 29, 2022
Semi-automated validation and quantification of CTLA-4 in 90 different tumor entities using multiple antibodies and artificial intelligenceDavid Dum, Tjark L C Henke, Tim Mandelkow, et al.
Scientific Reports|August 9, 2023
Cadherin-16 (CDH16) immunohistochemistry: a useful diagnostic tool for renal cell carcinoma and papillary carcinomas of the thyroidMaximilian Lennartz, Henrietta Csomós, Viktoria Chirico, et al.
Plos One|June 28, 2023
CELA3B immunostaining is a highly specific marker for acinar cell carcinoma of the pancreasRia Uhlig, Nina Bröker, Sören Weidemann, et al.
Biomedicines|April 30, 2021
Mesothelin Expression in Human Tumors: A Tissue Microarray Study on 12,679 TumorsSören Weidemann, Pauline Gagelmann, Natalia Gorbokon, et al.
Cancers|December 17, 2024
Carcinoembryonic Antigen Expression in Human Tumors: A Tissue Microarray Study on 13,725 TumorsKristina Jansen, Lara Kornfeld, Maximilian Lennartz, et al.
International Journal of Immunopathology and Pharmacology|June 28, 2022
Mucin 5AC expression is common but unrelated to tumor progression in pancreatic adenocarcinomaSebastian Dwertmann Rico, Franziska Büscheck, David Dum, et al.
Pathology Oncology Research : POR|July 18, 2020
Secreted Frizzled-Related Protein 4 (SFRP4) Is an Independent Prognostic Marker in Prostate Cancers Lacking TMPRSS2: ERG FusionsChristian Bernreuther, Ferdous Daghigh, Katharina Möller, et al.
Molecular Cancer Research : MCR|March 28, 2023
BLEACH&STAIN 15-marker Multiplexed Imaging in 3,098 Human Carcinomas Reveals Six Major PD-L1-driven Immune Phenotypes with Distinct Spatial OrchestrationElena Bady, Katharina Möller, Tim Mandelkow, et al.
Acta Oncologica (Stockholm, Sweden)|December 2, 2025
L1CAM/CD171 expression in human tumors and its association with tumor phenotypeSeyma Büyücek, Magalie Lurati, Katharina Möller, et al.
Molecular Medicine (Cambridge, Mass.)|June 29, 2026
Prevalence of heterozygous and homozygous 9p21 deletions in human cancer: a tissue microarray study on 4,999 tumors from 125 different tumor typesNatalia Gorbokon, Katharina Teljuk, Nina Schraps, et al.
Pageof 10